Navigation Links
Jefferson Department of Surgery announces new pancreas tumor registry
Date:10/29/2008

PHILADELPHIA Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR).

"The purpose of the registry is to further study whether pancreatic cancer occurs more frequently in families with a history of the disease," said Dr. Yeo, who is the principal investigator of JPTR. "It will also be used to determine the environmental and occupational risk factors to which pancreatic cancer patients have been exposed."

The JPTR modeled after the National Familial Pancreas Tumor Registry is a longitudinal study in which participants may engage in long-term follow-up and receive information regarding scientific and epidemiological breakthroughs in pancreatic cancer.

Participants are asked to complete a detailed questionnaire and may be asked to submit a blood sample and/or cheek swab. The questionnaires are designed to elicit the family health history of a patient with pancreatic cancer or a non-affected family member, and to document exposure to occupational and environmental factors, such as residential radon, asbestos and second-hand tobacco smoke.

Research has shown that certain rare genetic conditions are associated with an increased risk of pancreatic cancer, including familial breast-ovarian cancer, familial melanoma, familial colon cancer, hereditary pancreatitis and Peutz-Jegher's syndrome (a rare hereditary condition that results in gastrointestinal polyps). "While we have not identified a causative gene yet to allow predictive testing for pancreatic cancer, we can offer risk assessments and surveillance via imaging, blood tests and endoscopic ultrasound for patients with a strong family history of pancreatic cancer," added Dr. Yeo.

Such high risk patients may be referred to a Jefferson gastroenterologist to discuss the pros and cons of invasive surveillance. The goal is to diagnose pancreatic cancer earlier, when more treatment options are available. For persons who do develop pancreatic cancer, Jefferson physicians may use the results of genetic testing to select the most effective therapy. Targeted therapy for pancreatic cancer is becoming a reality, in part due to recent discoveries made in the laboratory of Jonathan Brody, Ph.D., assistant professor, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, where molecular studies have clearly indicated survival advantages with the use of targeted chemotherapy.


'/>"/>

Contact: Ed Federico
ed.federico@jefferson.edu
Thomas Jefferson University
Source:Eurekalert

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure
3. Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
4. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
5. Story tips from the Department of Energys Oak Ridge National Laboratory, September 2008
6. Story tips from the US Department of Energys Oak Ridge National Laboratory, August 2008
7. Second Life a first for UH department of health and human performance
8. Story tips from the Department of Energys Oak Ridge National Laboratory, July 2008
9. US Department of Energy Joint Genome Institute announces new genome sequencing projects
10. Story tips from the Department of Energys Oak Ridge National Laboratory, June 2008
11. Story tips from the Department of Energys Oak Ridge National Laboratory, April 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2020)... Md. (PRWEB) , ... May 15, 2020 , ... The ... boutique intellectual property law firm based in Frederick, Maryland and Tysons Corner, Virginia, to ... field of biotechnology and a another in the field of chemistry. The firm is ...
(Date:5/14/2020)... ... May 13, 2020 , ... DuPont ... latest enzyme for the lactose-free dairy market. This unique product allows for process ... dairy products at competitive costs across North America. , Among the numerous benefits ...
(Date:5/11/2020)... ... 2020 , ... Octagos Health, a Houston-based company, recently launched ... The Octagos software allows healthcare professionals access to cardiac patients’ pacemaker, defibrillator or ... remote transmissions and at the same time provides real-time patient insights and analytics ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of NEON® ... Solution, a highly accurate, contact tracing solution for identification of employees who may ... core disease control measure, is a key strategy for preventing further spread of ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... device, diagnostics, and animal health markets, has enabled Cytovale, Inc., a medical technology ... and machine learning, to achieve their first patient in (FPI) in just seven ...
(Date:5/26/2020)... , ... May 26, 2020 , ... Brilliant , ... recognized brand of smart garage door openers, announce a new integration to bring more ... enabled garage door openers powered by Aladdin Connect® can now be controlled from Brilliant’s ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... who will serve as the company’s executive vice president of product engineering and ... is disrupting the medical imaging space, bringing more than 24 years of technology ...
Breaking Biology Technology: